Assoc. Prof. Dr. Razieh Nazari is a distinguished academic and researcher in the fields of Microbiology and Medical Nanotechnology. Assoc. Prof. Dr. Razieh Nazari’s advanced expertise is demonstrated through extensive publications and professional experience. The professional career of Assoc. Prof. Dr. Razieh Nazari is marked by dedicated teaching and supervision, contributing significantly to both undergraduate and postgraduate programs. Assoc. Prof. Dr. Razieh Nazari’s primary research interests lie at the intersection of microbiology and material science, focusing extensively on nanobiotechnology, the biosynthesis of nanoparticles (such as selenium and silver nanoparticles using fungi or bacteria), and their applications in developing novel antimicrobial and antifungal agents against drug-resistant pathogens like Candida species and Acinetobacter baumannii. Further interests include the molecular epidemiology and development of new biosensors and diagnostic methods for infectious diseases, including H. pylori and Leishmania. Key research skills include molecular microbiology techniques (PCR, RFLP), nanoparticle synthesis and characterization, antimicrobial susceptibility testing, genosensing, and advanced data analysis for epidemiological studies. Assoc. Prof. Dr. Razieh Nazari’s commitment to high-impact research has resulted in recognition, including various awards and honors related to successful research projects and publications. In conclusion, Assoc. Prof. Dr. Razieh Nazari is a highly productive and influential researcher, dedicated to leveraging nanotechnology and microbiology to combat antibiotic resistance and advance diagnostic platforms for infectious diseases, thus making a critical contribution to public health and medical science
Nazari, R., Godarzi, H., Baghi, F. R., & Moeinrad, M. (2014). Enterotoxin gene profiles among Staphylococcus aureus isolated from raw milk. Iranian journal of veterinary research, 15(4), 409. (49 Citations)
Hosseini Bafghi, M., Darroudi, M., Zargar, M., Zarrinfar, H., & Nazari, R. (2021). Biosynthesis of selenium nanoparticles by Aspergillus flavus and Candida albicans for antifungal applications. Micro & Nano Letters, 16(14), 656–669. (45 Citations)
Sarikhani, Z., Nazari, R., & Rostami, M. N. (2017). First report of OXA-143-$\beta$-lactamase producing Acinetobacter baumannii in Qom, Iran. Iranian Journal of Basic Medical Sciences, 20(11), 1282. (41 Citations)
Hosseini Bafghi, M., Zarrinfar, H., Darroudi, M., Zargar, M., & Nazari, R. (2022). Green synthesis of selenium nanoparticles and evaluate their effect on the expression of ERG3, ERG11 and FKS1 antifungal resistance genes in Candida albicans and Candida glabrata. Letters in Applied Microbiology, 74(5), 809–819. (38 Citations)
Hosseini Bafghi, M., Nazari, R., Darroudi, M., Zargar, M., & Zarrinfar, H. (2022). Evaluation and comparison of the effects of biosynthesized selenium and silver nanoparticles using plant extracts with antifungal drugs on the growth of Aspergillus and Candida. Biotechnology Progress, 38(1), e3206. (33 Citations)
Rostami, M. N., Rashidi, B. H., Habibi, A., Nazari, R., & Dolati, M. (2017). Genital infections and reproductive complications associated with Trichomonas vaginalis, Neisseria gonorrhoeae, and Streptococcus agalactiae in women of Qom, central Iran. International journal of reproductive biomedicine, 15(6), 357. (23 Citations)
Rostami, M. N., Rashidi, B. H., Nazari, R., Aghsaghloo, F., & Habibi, A. (2017). A multiplex assay of Trichomonas vaginalis, Chlamydia trachomatis and Neisseria gonorrhoeae infections in genital specimens. The Journal of Infection in Developing Countries, 11(11), 833–839. (17 Citations)